ArticleQuantitative imaging in medicine and surgery2026
Correlation between contrast-enhanced T2 fluid-attenuated inversion recovery enhancement and dynamic contrast-enhanced magnetic resonance imaging permeability in brain metastases.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dynamic Contrast-Enhanced MRI in Neuro-Oncology: A Narrative and Translational Review.Brain sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Contrast-enhanced T2 fluid-attenuated inversion recovery (CE-T2 FLAIR) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) provide complementary information on lesion enhancement and vascular permeability. This study aimed to assess the correlation between CE-T2 FLAIR enhancement and DCE-MRI-derived permeability parameters in brain metastases. Methods: This single-center retrospective study included 43 patients with 80 brain metastases confirmed by pathology or follow-up between January 2018 and July 2024. All patients underwent T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), T2 FLAIR, DCE-MRI, CE-T2 FLAIR, and contrast-enhanced T1WI (CE-T1WI) examinations. Quantitative DCE-MRI parameters were evaluated for all lesions, including the volume transfer constant (K Results: Groups A, B, and C included 17, 45, and 18 lesions, respectively. Group A showed significantly higher CR and PI and lower K Conclusions: Vascular permeability of brain metastases is a key factor contributing to the differential enhancement observed between CE-T2 FLAIR and CE-T1WI, with CE-T2 FLAIR demonstrating superior sensitivity in detecting metastases with low vascular permeability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.